Questions, answered.

No. Sermorelin is a peptide — a short chain of amino acids that signals your pituitary gland to release its own growth hormone. Anabolic steroids are synthetic analogs of testosterone that replace endogenous production. The mechanisms, risks, and physiologic effects are fundamentally different.

Same compound, different delivery. The nasal spray uses intranasal absorption — bioavailability is lower than subcutaneous injection but the convenience and tolerability are significantly higher. Injectable Sermorelin has a faster onset and a higher peak; the nasal spray produces a smoother, more gradual release. For men whose primary use case is nightly sleep and recovery support, the nasal spray is often the better fit.

Both are non-injectable Sermorelin formats with similar bioavailability profiles. The nasal spray is the fastest format to administer — three sprays, two minutes — and the dose can be titrated up to three sprays as your physician directs. The sublingual troche dissolves passively between cheek and gum (no action needed once it's in) and has a 180-day shelf life vs. 35 days for the spray. Either is a solid starting format; your physician can help you choose based on your routine and preference.

Yes, and many men do. Sermorelin pairs well with testosterone replacement therapy and with peptides like BPC-157 (for tissue recovery). The protocol your physician builds will account for any other prescriptions you're on. Disclose everything in your assessment — especially if you take corticosteroids or thyroid medications, which can interact with Sermorelin.

Sermorelin is well tolerated in most men. Possible side effects include mild nasal irritation, transient flushing, dizziness, and headache — reported in less than 1% of patients.

Sermorelin isn't appropriate for men with active malignancy or certain pituitary or endocrine conditions. Your physician screens for these during the medical assessment, along with any potential interactions with your current medications.

Sleep changes typically show up within the first week or two. Recovery, mental clarity, and skin effects build over the following weeks. Body composition changes are most visible by week 8. This is not an acute-effect compound — the value comes from sustained nightly use over months.

No. Sermorelin is a peptide — a short chain of amino acids that signals your pituitary gland to release its own growth hormone. Anabolic steroids are synthetic analogs of testosterone that replace endogenous production. The mechanisms, risks, and physiologic effects are fundamentally different.

Same compound, different delivery. The troche uses buccal absorption — it dissolves between your cheek and gum and absorbs through the oral mucosa, bypassing the digestive tract. Bioavailability is lower than subcutaneous injection but the convenience and tolerability are significantly higher. Injectable Sermorelin has a faster onset and a higher peak; the troche produces a smoother, more gradual release. For men whose primary use case is nightly sleep and recovery support, the troche is often the better fit.

Both are non-injectable Sermorelin formats with similar bioavailability profiles. The troche dissolves passively between cheek and gum — no action needed once it's in. The nasal spray is fastest at the point of administration (three sprays, two minutes). The troche has a 180-day shelf life vs. 35 days for the nasal spray, which can mean fewer reorders. Either is a solid starting format; your physician can help you choose based on your routine and preference.

Yes, and many men do. Sermorelin pairs well with testosterone replacement therapy and with peptides like BPC-157 (for tissue recovery). The protocol your physician builds will account for any other prescriptions you're on. Disclose everything in your assessment — especially if you take corticosteroids or thyroid medications, which can interact with Sermorelin.

Sermorelin is well tolerated in most men. Possible side effects include transient flushing, dizziness, and headache — reported in less than 1% of patients.

Sermorelin isn't appropriate for men with active malignancy or certain pituitary or endocrine conditions. Your physician screens for these during the medical assessment, along with any potential interactions with your current medications.

Sleep changes typically show up within the first week or two. Recovery, mental clarity, and skin effects build over the following weeks. Body composition changes are most visible by week 8. This is not an acute-effect compound — the value comes from sustained nightly use over months.

Tirzepatide is the active compound in all three. Mounjaro and Zepbound are FDA-approved finished products made by a single manufacturer. EdgeRx's protocol uses tirzepatide compounded by a US-licensed 503A pharmacy and formulated together with glycine and B12. Compounded medications are prepared for an individual patient on a physician's prescription and are not FDA-approved as finished products. Your physician determines whether a compounded tirzepatide protocol is appropriate for you.

Significant weight loss reduces fat, and without attention to it, some lean muscle as well. Glycine is an amino acid studied for its role in limiting the breakdown of muscle protein during calorie restriction; it is included to support muscle preservation while you lose fat. Vitamin B12 supports nutrient repletion during a period of reduced food intake and may help reduce early nausea. Together, they are why EdgeRx's protocol is built around body composition rather than weight loss alone.

Both are once-weekly GLP-1 injections formulated with glycine and B12. Tirzepatide is a dual agonist that activates both the GLP-1 and GIP receptors, while semaglutide acts on the GLP-1 receptor alone. Men and their physicians often consider semaglutide as a starting GLP-1 protocol and tirzepatide as a step up, but that is a clinical decision: your physician recommends one based on your history, your goals, and how you respond. Either protocol is titrated and physician-managed.

Tirzepatide should not be combined with any other GLP-1 medication, including semaglutide, and your physician screens for this. Beyond that, many men run a metabolic protocol alongside protocols from other categories. The protocol your physician builds accounts for everything else you are taking, so disclose your full medication list during the medical assessment.

The most common side effects are gastrointestinal: nausea and constipation most often, and sometimes acid reflux, stomach pain, vomiting, diarrhea, or less commonly an altered skin sensation. They tend to be most noticeable in the early weeks and as the dose steps up, which is why the protocol is titrated gradually. The risk of more serious effects is higher in men with hypoglycemia, kidney problems, or a history of allergic reactions. Your physician reviews your risk before prescribing and adjusts the protocol if side effects are hard to tolerate.

Tirzepatide is not appropriate for everyone. It should not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and it is not for use during pregnancy or breastfeeding. It is not insulin and is not a treatment for type 1 diabetes. Men with a history of pancreatitis, kidney problems, or diabetic retinopathy need careful physician evaluation first. Because tirzepatide slows stomach emptying, tell any provider about your protocol before a planned surgery or procedure involving anesthesia or sedation. Your physician screens for all of this during the medical assessment.

Most men notice reduced appetite and fewer cravings within the first few weeks. Visible changes in weight and body composition come more gradually, over months, as the dose is titrated up and the protocol settles into a maintenance range. Tirzepatide is a sustained protocol: the results come from consistent use over time, not from any single injection.

Semaglutide is the active compound in all three. Ozempic and Wegovy are FDA-approved finished products made by a single manufacturer. EdgeRx's protocol uses semaglutide compounded by a US-licensed 503A pharmacy and formulated together with glycine and B12. Compounded medications are prepared for an individual patient on a physician's prescription and are not FDA-approved as finished products. Your physician determines whether a compounded semaglutide protocol is appropriate for you.

Significant weight loss reduces fat, and without attention to it, some lean muscle as well. Glycine is an amino acid studied for its role in limiting the breakdown of muscle protein during calorie restriction; it is included to support muscle preservation while you lose fat. Vitamin B12 supports nutrient repletion during a period of reduced food intake and may help reduce early nausea. Together, they are why EdgeRx's protocol is built around body composition rather than weight loss alone.

Both are once-weekly GLP-1 injections formulated with glycine and B12. Semaglutide acts on the GLP-1 receptor alone, while tirzepatide is a dual agonist that activates both the GLP-1 and GIP receptors. Men and their physicians often consider semaglutide as a starting GLP-1 protocol and tirzepatide as a step up, but that is a clinical decision: your physician recommends one based on your history, your goals, and how you respond. Either protocol is titrated and physician-managed.

Semaglutide should not be combined with any other GLP-1 medication, including tirzepatide, and your physician screens for this. Beyond that, many men run a metabolic protocol alongside protocols from other categories. The protocol your physician builds accounts for everything else you are taking, so disclose your full medication list during the medical assessment.

The most common side effects are gastrointestinal: nausea and constipation most often, and sometimes acid reflux, stomach pain, vomiting, diarrhea, or a reaction at the injection site. They tend to be most noticeable in the early weeks and as the dose steps up, which is why the protocol is titrated gradually. The risk of more serious effects is higher in men with hypoglycemia, kidney problems, or a history of allergic reactions. Your physician reviews your risk before prescribing and adjusts the protocol if side effects are hard to tolerate.

Semaglutide is not appropriate for everyone. It should not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and it is not for use during pregnancy or breastfeeding. It is not insulin and is not a treatment for type 1 diabetes. Men with a history of pancreatitis, kidney problems, or diabetic retinopathy need careful physician evaluation first. Because semaglutide slows stomach emptying, tell any provider about your protocol before a planned surgery or procedure involving anesthesia or sedation. Your physician screens for all of this during the medical assessment.

Most men notice reduced appetite and fewer cravings within the first few weeks. Visible changes in weight and body composition come more gradually, over months, as the dose is titrated up and the protocol settles into a maintenance range. Semaglutide is a sustained protocol: the results come from consistent use over time, not from any single injection.

MICC is the lipotropic injection those names usually refer to — a combination of methionine, inositol, choline, and vitamin B12. The difference is not the compound; it is the context. EdgeRx's MICC is prescribed by a US board-certified physician who reviews your history first, and it is described for what the nutrients actually do — support fat metabolism and energy — rather than marketed as a shortcut. Your physician determines whether MICC is appropriate for you.

Methionine is an essential amino acid involved in the liver's processing of fat. Choline, an essential nutrient, helps transport fat out of the liver and supports liver health. Inositol works alongside choline in regulating lipid metabolism. Vitamin B12 supports energy production and metabolic rate. Together they are the lipotropic-plus-B12 combination MICC is built on — nutrients the body's fat-metabolism and energy pathways depend on.

Tirzepatide and Semaglutide are GLP-1 protocols: they act on appetite signaling and the hormones that regulate blood sugar, and they are titrated over time. MICC is not a GLP-1. It is a lipotropic and B12 injection that supports fat metabolism and energy through nutrient pathways, at a fixed dose with no titration. It does not suppress appetite the way a GLP-1 does. Men sometimes consider MICC on its own, and sometimes alongside a GLP-1 — but combining protocols is a clinical decision your physician makes based on your history and goals.

Often, yes. Because MICC works through nutrient pathways rather than hormone signaling, it can be considered alongside protocols from other categories, and in some cases alongside a GLP-1 protocol — but that is a decision your physician makes, not a default. The protocol your physician builds accounts for everything else you are taking, so disclose your full medication list during the medical assessment.

MICC is generally well tolerated. The most common effect is a temporary reaction at the injection site — mild soreness, redness, or warmth. Some men notice a brief flush or mild gastrointestinal upset after a dose. Your physician reviews your individual risk before prescribing and adjusts the schedule if any effect is hard to tolerate. Tell your physician about anything you experience between check-ins.

MICC is not appropriate for everyone. It should not be used by anyone with a known allergy to any of its components, and men with significant liver or kidney conditions need careful physician evaluation first. It is not intended for use during pregnancy or breastfeeding. Your physician reviews your full medical history during the assessment to determine whether MICC is appropriate for you.

Some men notice the B12-driven lift in energy within the first few weeks. The support MICC provides for fat metabolism is gradual and depends on your diet and training alongside it — MICC is not a standalone fat-loss treatment. It is a sustained protocol: the value comes from consistent use over time, not from any single injection.

No. Over-the-counter libido and "testosterone-booster" supplements are supplement-grade products sold without a prescription or physician oversight, and their ingredients are not PT-141. EdgeRx's protocol uses PT-141 itself — bremelanotide — compounded by a US-licensed pharmacy, delivered as a nasal spray, and prescribed by a board-certified physician. Same goal, different category: a prescription protocol rather than a shelf supplement.

PT-141 and the familiar erectile-function medications work in different places. The erectile-function medications act on blood flow. PT-141 works earlier in the process — on the melanocortin receptor pathways in the brain involved in sexual desire and arousal. It targets the wanting, not the mechanics. That is why it is a libido and arousal protocol rather than an erectile-function one. Whether PT-141 fits your goal is something your physician confirms during the medical assessment.

EdgeRx offers PT-141 in two formats, and both deliver the same compound. The nasal spray is taken as two sprays, about 30 minutes before sexual activity. The sublingual troche dissolves under your tongue and is taken about 30 to 60 minutes before. The choice is mostly preference: some men prefer the nasal spray, others prefer a troche that dissolves on its own with no device. Your physician can help you choose, and you can switch formats at a check-in.

Yes. Men often run PT-141 alongside other protocols in the catalog. The protocol your physician builds accounts for everything else you are taking, so disclose your full medication list during the medical assessment. One specific note: PT-141 can affect blood pressure, so your physician will pay particular attention to any blood-pressure medication or cardiovascular history.

PT-141 is well tolerated by most men. The most common effects are nausea and flushing, and some men notice headache; these are usually mild and pass. Because the nasal spray is absorbed through nasal tissue, some men also notice brief nasal irritation. Less commonly, PT-141 can raise blood pressure or increase heart rate, and longer use has been associated with darkening of the skin or gums in some people. Your physician reviews your history during the medical assessment and tells you what to watch for.

PT-141 is not appropriate for everyone. Men with uncontrolled high blood pressure or significant cardiovascular disease should tell their physician — PT-141 can raise blood pressure, and it is not appropriate where that is a concern. PT-141 is discontinued if a rapid heartbeat develops. Your physician screens for these during the medical assessment, along with any interactions with your current medications.

PT-141 is taken as needed, about 30 minutes before sexual activity, and most men feel its effect the same session — there is no daily build-up and no loading period. It is designed for use in the moment rather than as a daily protocol. If the first dose does not produce the response you are looking for, your physician may adjust the timing or your dose at a check-in.

No. Over-the-counter libido and "testosterone-booster" supplements are supplement-grade products sold without a prescription or physician oversight, and their ingredients are not PT-141. EdgeRx's protocol uses PT-141 itself, bremelanotide, compounded by a US-licensed pharmacy, delivered as a sublingual troche, and prescribed by a board-certified physician. Same goal, different category: a prescription protocol rather than a shelf supplement.

PT-141 and the familiar erectile-function medications work in different places. The erectile-function medications act on blood flow. PT-141 works earlier in the process — on the melanocortin receptor pathways in the brain involved in sexual desire and arousal. It targets the wanting, not the mechanics. That is why it is a libido and arousal protocol rather than an erectile-function one. Whether PT-141 fits your goal is something your physician confirms during the medical assessment.

EdgeRx offers PT-141 in two formats, and both deliver the same compound. The sublingual troche dissolves under your tongue and is taken about 30 to 60 minutes before sexual activity. The nasal spray is taken as two sprays, about 30 minutes before. The choice is mostly preference: some men prefer the troche for its discretion and the absence of any device, others prefer the slightly shorter window of the nasal spray. Your physician can help you choose, and you can switch formats at a check-in.

Yes. Men often run PT-141 alongside other protocols in the catalog. The protocol your physician builds accounts for everything else you are taking, so disclose your full medication list during the medical assessment. One specific note: PT-141 can affect blood pressure, so your physician will pay particular attention to any blood-pressure medication or cardiovascular history.

PT-141 is well tolerated by most men. The most common effects are nausea and flushing, and some men notice headache; these are usually mild and pass. Because the troche dissolves under the tongue, some men also notice a mild taste or brief tingling where it dissolves. Less commonly, PT-141 can raise blood pressure or increase heart rate, and longer use has been associated with darkening of the skin or gums in some people. Your physician reviews your history during the medical assessment and tells you what to watch for.

PT-141 is not appropriate for everyone. Men with uncontrolled high blood pressure or significant cardiovascular disease should tell their physician — PT-141 can raise blood pressure, and it is not appropriate where that is a concern. PT-141 is discontinued if a rapid heartbeat develops. Your physician screens for these during the medical assessment, along with any interactions with your current medications.

PT-141 is taken as needed, about 30 to 60 minutes before sexual activity, and most men feel its effect the same session — there is no daily build-up and no loading period. It is designed for use in the moment rather than as a daily protocol. If the first dose does not produce the response you are looking for, your physician may adjust the timing or your dose at a check-in.

No. Over-the-counter libido and "testosterone-booster" supplements are supplement-grade products sold without a prescription or physician oversight, and their ingredients are not PT-141 or oxytocin. Olympus combines PT-141 (bremelanotide) and oxytocin, compounded together by a US-licensed pharmacy, delivered as a sublingual tablet, and prescribed by a board-certified physician. Same goal, different category: a prescription protocol rather than a shelf supplement.

Desire is not a single thing. PT-141 works in the brain on the pathways behind sexual desire and arousal; oxytocin is associated with receptivity, trust, and the sense of connection between partners. Olympus pairs the two so the protocol addresses both the wanting and the closeness, rather than only one. The two compounds are compounded together into a single sublingual tablet, so it is one tablet, not two.

Olympus pairs two compounds, PT-141 and oxytocin, and is built around sexual desire and connection. Olympus + adds a third compound, Tadalafil, which works on blood flow to support erectile firmness. The two share the same desire-and-connection pairing; Olympus + is the option for the men who also want erectile firmness addressed in the same protocol. Your physician helps confirm which one fits your history and goals.

Olympus and the familiar erectile-function medications work in different places. The erectile-function medications act on blood flow. Olympus works earlier in the process — PT-141 on the brain pathways behind sexual desire and arousal, and oxytocin on receptivity and connection. It is a desire and connection protocol, not an erectile-function one. Whether Olympus fits your goal is something your physician confirms during the medical assessment.

Yes. Men often run Olympus alongside other protocols in the catalog. The protocol your physician builds accounts for everything else you are taking, so disclose your full medication list during the medical assessment. One specific note: the PT-141 in Olympus can affect blood pressure, so your physician will pay particular attention to any blood-pressure medication or cardiovascular history.

Olympus is well tolerated by most men. The most common effects are nausea and flushing, and some men notice headache; these are usually mild and pass. Because the tablet dissolves under the tongue, some men also notice a mild taste or brief tingling where it dissolves. Less commonly, the PT-141 in Olympus can raise blood pressure or increase heart rate, and longer use of bremelanotide has been associated with darkening of the skin or gums in some people. Your physician reviews your history during the medical assessment and tells you what to watch for.

Olympus is not appropriate for everyone. Men with uncontrolled high blood pressure or significant cardiovascular disease should tell their physician — the PT-141 in Olympus can raise blood pressure, and it is not appropriate where that is a concern. Olympus is discontinued if a rapid heartbeat develops. Your physician screens for these during the medical assessment, along with any interactions with your current medications.

No. Over-the-counter libido, "testosterone-booster," and erectile supplements are supplement-grade products sold without a prescription or physician oversight, and their ingredients are not PT-141, oxytocin, or Tadalafil. Olympus + combines all three, compounded together by a US-licensed pharmacy, delivered as a sublingual tablet, and prescribed by a board-certified physician. Same goal, different category: a prescription protocol rather than a shelf supplement.

Sexual function is not a single thing. PT-141 works in the brain on the pathways behind desire and arousal; oxytocin is associated with receptivity and the sense of connection between partners; Tadalafil works on blood flow to support erectile firmness. Olympus + combines all three so the protocol addresses the wanting, the closeness, and the physical side together, rather than only one. The three compounds are compounded into a single sublingual tablet, so it is one tablet, not three.

Olympus pairs two compounds, PT-141 and oxytocin, and is built around sexual desire and connection. Olympus + adds a third compound, Tadalafil, which works on blood flow to support erectile firmness. The two share the same desire-and-connection pairing; Olympus + is the option for the men who also want erectile firmness addressed in the same protocol. Your physician helps confirm which one fits your history and goals.

A standard erectile-function medication is a single compound that works on blood flow alone. Olympus + includes that mechanism — Tadalafil is one of its three compounds — but it is built around more than blood flow. PT-141 acts on the brain pathways behind sexual desire and arousal, and oxytocin on receptivity and connection. Olympus + is a combination protocol that addresses desire and connection alongside erectile firmness, not a single-compound one. Whether it fits your goal is something your physician confirms during the medical assessment.

Some of it depends on what else you take. The protocol your physician builds accounts for your full medication list, so disclose everything during the medical assessment. Two interactions matter most here. The Tadalafil in Olympus + must not be combined with nitrate medications, such as nitroglycerin and other nitrates prescribed for chest pain, because the combination can cause a dangerous drop in blood pressure. And both the Tadalafil and the PT-141 can affect blood pressure, so your physician will pay particular attention to any blood-pressure medication, alpha-blocker, or cardiovascular history.

Olympus + is well tolerated by most men. The most common effects are headache, flushing, and nausea; some men also notice nasal congestion, dizziness, indigestion, or muscle or back pain, and these are usually mild and pass. Because the tablet dissolves under the tongue, some men notice a mild taste or brief tingling where it dissolves. Less commonly, the compounds in Olympus + can raise blood pressure or heart rate, Tadalafil can cause temporary changes in vision, and longer use of the bremelanotide component has been associated with darkening of the skin or gums in some people. A prolonged erection lasting more than four hours is rare but needs prompt medical attention. Your physician reviews your history during the medical assessment and tells you what to watch for.

Olympus + is not appropriate for everyone. Men who take nitrate medications, such as nitroglycerin or other nitrates prescribed for chest pain, should not take Olympus +, because combining nitrates with the Tadalafil it contains can cause a dangerous drop in blood pressure. Men with uncontrolled high blood pressure, significant cardiovascular disease, or a heart condition that makes sexual activity inadvisable should tell their physician; both the Tadalafil and the PT-141 can affect blood pressure. Olympus + is discontinued if a rapid heartbeat develops or if vision or hearing changes occur. Your physician screens for all of this during the medical assessment, along with any interactions with your current medications.

No. Over-the-counter libido and "testosterone-booster" supplements are supplement-grade products sold without a prescription or physician oversight, and their ingredients are not oxytocin. EdgeRx's protocol uses oxytocin itself, the neuropeptide, compounded by a US-licensed pharmacy, delivered as a nasal spray, and prescribed by a board-certified physician. Same goal, different category: a prescription protocol rather than a shelf supplement.

They work in different places. The familiar erectile-function medications act on blood flow. Oxytocin works on the brain pathways involved in arousal, satisfaction, and emotional connection — it is associated with the connection and closeness side of intimacy rather than the mechanics of an erection. That is why it sits in the libido and arousal category rather than the erectile-function one. Whether oxytocin fits your goal is something your physician confirms during the medical assessment.

EdgeRx offers oxytocin in two formats, and both deliver the same compound. The nasal spray is absorbed rapidly through the nasal lining and keeps for 35 days once opened. The sublingual troche dissolves under your tongue, with no device, and keeps for 180 days when refrigerated. The choice is mostly preference — some men prefer the spray, others prefer a troche that dissolves on its own with no device. Your physician can help you choose, and you can switch formats at a check-in.

Yes. Men often run oxytocin alongside other protocols in the catalog. The protocol your physician builds accounts for everything else you are taking, so disclose your full medication list during the medical assessment. Your physician will also account for any heart, blood-pressure, or breathing condition when deciding whether oxytocin is appropriate and how it is dosed.

Oxytocin is generally well tolerated. The most common effects are nausea, headache, and dizziness, usually mild. Because it is delivered as a nasal spray, some men also notice nasal irritation or, less commonly, a brief nosebleed. Rarely, oxytocin can cause shortness of breath. With regular use it can have a mild antidiuretic effect, which your physician will account for. Your physician reviews your history during the medical assessment and tells you what to watch for.

Oxytocin is not right for everyone. Men with a history of heart disease, severe asthma, or epilepsy should tell their physician — oxytocin is used cautiously in those cases and only under close guidance. Your physician screens for these during the medical assessment, along with any interactions with your current medications, and decides whether oxytocin is appropriate for you.

It depends on how your physician structures the protocol. The nasal spray is absorbed rapidly: when oxytocin is used ahead of intimacy, most men feel its effect the same session, with no loading period to wait through. When it is used on a regular basis, the intent is steadier day-to-day support over time. If the first uses do not produce the response you are looking for, your physician may adjust the dose or timing at a check-in.

No. Over-the-counter libido and "testosterone-booster" supplements are supplement-grade products sold without a prescription or physician oversight, and their ingredients are not oxytocin. EdgeRx's protocol uses oxytocin itself, the neuropeptide, compounded by a US-licensed pharmacy, delivered as a sublingual troche, and prescribed by a board-certified physician. Same goal, different category: a prescription protocol rather than a shelf supplement.

They work in different places. The familiar erectile-function medications act on blood flow. Oxytocin works on the brain pathways involved in arousal, satisfaction, and emotional connection — it is associated with the connection and closeness side of intimacy rather than the mechanics of an erection. That is why it sits in the libido and arousal category rather than the erectile-function one. Whether oxytocin fits your goal is something your physician confirms during the medical assessment.

EdgeRx offers oxytocin in two formats, and both deliver the same compound. The sublingual troche dissolves under your tongue, with no device, and keeps for 180 days when refrigerated. The nasal spray is absorbed rapidly through the nasal lining and keeps for 35 days once opened. The choice is mostly preference — some men prefer the troche for its simplicity and the absence of any device, others prefer the spray. Your physician can help you choose, and you can switch formats at a check-in.

Yes. Men often run oxytocin alongside other protocols in the catalog. The protocol your physician builds accounts for everything else you are taking, so disclose your full medication list during the medical assessment. Your physician will also account for any heart, blood-pressure, or breathing condition when deciding whether oxytocin is appropriate and how it is dosed.

Oxytocin is generally well tolerated. The most common effects are nausea, headache, and dizziness, usually mild. Because the troche dissolves under the tongue, some men also notice a mild taste or brief tingling where it dissolves. Rarely, oxytocin can cause shortness of breath. With regular use it can have a mild antidiuretic effect, which your physician will account for. Your physician reviews your history during the medical assessment and tells you what to watch for.

Oxytocin is not right for everyone. Men with a history of heart disease, severe asthma, or epilepsy should tell their physician — oxytocin is used cautiously in those cases and only under close guidance. Your physician screens for these during the medical assessment, along with any interactions with your current medications, and decides whether oxytocin is appropriate for you.

It depends on how your physician structures the protocol. The troche dissolves under the tongue and is absorbed from there: when oxytocin is used ahead of intimacy, most men feel its effect the same session, with no loading period to wait through. When it is used on a regular basis, the intent is steadier day-to-day support over time. If the first uses do not produce the response you are looking for, your physician may adjust the dose or timing at a check-in.

No. TRT, or testosterone replacement therapy, supplies testosterone from outside the body. The brain reads that added testosterone as sufficient and reduces its own LH and FSH, which over time lowers natural testosterone production and the testicular function tied to fertility. Enclomiphene works the other way: it raises LH and FSH so the body produces more of its own testosterone, and that signaling is preserved. The goal is similar, a healthier testosterone level, but the mechanism differs — and your physician helps you decide which fits your history and what you want to protect.

Enclomiphene raises LH and FSH, the same hormones involved in sperm production — so unlike testosterone replacement, it does not suppress fertility, and it is often chosen specifically by men who want to keep their fertility intact. Your physician reviews your goals during the assessment, including whether maintaining fertility is one of them, and accounts for it in the protocol.

Clomiphene is made up of two isomers. Enclomiphene is one of them, the trans-isomer, isolated and used on its own. The other isomer carries more estrogenic activity; separating it out gives enclomiphene a more targeted antiestrogen effect. In men, that is associated with a lower risk of the mood changes and estrogen-related effects, such as breast tissue changes, that are sometimes seen with clomiphene. Your physician can explain how this applies to your situation.

Both are hormone-support protocols that raise the body's own testosterone, and both preserve fertility — but they act at different points. Enclomiphene works in the brain: it blocks an estrogen feedback signal, so the brain increases its own output of LH and FSH. Gonadorelin works one step earlier: it is the GnRH signal itself, prompting the pituitary directly. Enclomiphene is a daily tablet; gonadorelin is a sublingual tablet taken a few times a week. Your physician helps you decide which fits your bloodwork, your history, and your goals.

Yes. Enclomiphene is a hormone protocol, and bloodwork is part of it, not an optional add-on. Your physician orders baseline labs (testosterone, LH, FSH, and estradiol) before prescribing, and follow-up labs to confirm the protocol is working and to guide the dose. The lab results are what the protocol is built and adjusted around.

Enclomiphene is generally well tolerated. The most common effects are headache and nausea, usually mild. Some men notice changes in mood. Visual disturbances such as blurring can occur but are uncommon with enclomiphene — tell your physician promptly if you notice any change in your vision. The risk of breast tissue changes is lower with enclomiphene than with clomiphene. Your physician reviews your individual risk before prescribing and monitors you through your bloodwork and check-ins.

Enclomiphene is not appropriate for everyone. It raises testosterone only when the low level comes from reduced signaling from the brain — it will not raise testosterone when the testes themselves cannot respond, the pattern in primary hypogonadism, where LH is already high. It is not for anyone with a known allergy to its components. Men with a history of eye conditions, mood disorders, or liver conditions should tell their physician, who weighs them before prescribing. Your physician reviews your full medical history and bloodwork during the assessment to determine whether enclomiphene is appropriate for you.

Enclomiphene clears the body quickly, so the rise in LH and FSH it drives begins within the first days on the protocol. The change men tend to notice, in energy, drive, and recovery, develops over the following weeks as testosterone moves into a healthier range. Your physician confirms that with bloodwork. It is a sustained protocol — the value comes from consistent use and the lab-guided adjustments over time, not from any single tablet.

No. TRT, or testosterone replacement therapy, supplies testosterone from outside the body. The brain reads that added testosterone as sufficient and reduces its own GnRH, LH, and FSH, which over time lowers natural testosterone production and the testicular function tied to it. Gonadorelin works the other way: it supplies the GnRH signal, so the pituitary releases LH and FSH and the body produces more of its own testosterone. The goal is similar, a healthier testosterone level, but the mechanism differs — and your physician helps you decide which fits your history and what you want to protect.

Gonadorelin drives LH and FSH, the hormones involved in sperm production — so unlike testosterone replacement, it does not suppress fertility, and it is often chosen specifically by men who want to keep their testicular function and fertility intact. Your physician reviews your goals during the assessment, including whether maintaining fertility is one of them, and accounts for it in the protocol.

Both are hormone-support protocols that raise the body's own testosterone, and both preserve fertility — but they act at different points. Enclomiphene works in the brain: it blocks an estrogen feedback signal, so the brain increases its own output of LH and FSH. Gonadorelin works one step earlier: it is the GnRH signal itself, prompting the pituitary directly. One is a daily tablet, the other a sublingual tablet taken a few times a week. Your physician helps you decide which fits your bloodwork, your history, and your goals.

Yes. Gonadorelin is a hormone protocol, and bloodwork is part of it, not an optional add-on. Your physician orders baseline labs (testosterone, LH, and FSH, along with sperm parameters where fertility is a goal) before prescribing, and follow-up labs to confirm the protocol is working and to guide the dose and any cycling. The lab results are what the protocol is built and adjusted around.

Gonadorelin is generally well tolerated. The most common effects are headache, nausea, abdominal pain, and flushing, usually mild. Some hormone protocols are cycled, with planned breaks, partly to reduce the chance of side effects over time. Your physician reviews your individual risk before prescribing and monitors you through your bloodwork and check-ins.

Gonadorelin is not appropriate for everyone. It supports testosterone only when the low level comes from reduced signaling — it will not raise testosterone when the testes themselves can no longer respond. It is not for anyone with a known allergy to its components. Your physician reviews your full medical history and bloodwork during the assessment to determine whether gonadorelin is appropriate for you.

Gonadorelin acts on the pituitary quickly, so the rise in LH and FSH it drives begins soon after you start. The change men tend to notice, in energy and drive, develops over the following weeks as testosterone moves into a healthier range, and your physician confirms that with bloodwork. It is a sustained protocol, often cycled — the value comes from consistent use and lab-guided adjustment over time, not from any single tablet.